G Genpact
- 45.820
- +1.180+2.64%
- 45.820
- 0.0000.00%
Genpact News
Genpact Announces Renewed Partnership With Ferring Pharmaceuticals
TD Cowen Maintains Genpact(G.US) With Hold Rating, Maintains Target Price $45
Balanced Optimism and Caution in Genpact's Strategic Shift: Hold Rating Amid Uncertain Long-term Impact
Genpact Recognized as a Leader in Procurement Outsourcing Services in the 2024 Everest Group PEAK Matrix Assessment
Genpact Named to Forbes' World's Best Employers 2024 List for Fourth Consecutive Year
Is There An Opportunity With Genpact Limited's (NYSE:G) 47% Undervaluation?
Genpact(G.US) Officer Sells US$3.25 Million in Common Stock
Genpact Insider Sold Shares Worth $3,252,158, According to a Recent SEC Filing
Genpact Named a Leader in Avasant's 2024 Insurance Business Process Transformation RadarView Report
Genpact Third Quarter 2024 Earnings: Beats Expectations
Form 144 | Genpact(G.US) Officer Proposes to Sell 3.22 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 12, $Genpact(G.US)$ Officer Mehta Piyush intends to sell 70,000 shares of its common stock on Nov 12, with a total market value of approximately $3.22 million. Source:
Press Release: Genpact Announces Chief Strategy and Corporate Development Officer
Genpact | 10-Q: Q3 2024 Earnings Report
Mizuho Securities Maintains Genpact(G.US) With Hold Rating
Genpact: Balancing Growth Prospects With Challenges – Hold Rating Maintained
Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating
CNEXT Presents: How Inclusive Leadership Transforms Organizations for Future Growth
Genpact Is Maintained at Buy by Needham
Express News | Genpact Ltd : Needham Raises Target Price to $55 From $42
Is There An Opportunity With Genpact Limited's (NYSE:G) 46% Undervaluation?
Analysis
Price Target
No Data
No Data